Searched for
ALKEM PHARMA
Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...08 May, 2026, 08.54 AM IST- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...06 May, 2026, 11.56 AM IST
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...29 Apr, 2026, 02.22 PM IST
- Rs 12,000 crore magic pill race begins to shrink India's pot bellies. Which pharma stocks will win GLP-1 war?India's GLP-1 market is set for a massive boom. Following patent expiry, generic versions of semaglutide are launching at significantly low...24 Mar, 2026, 11.14 AM IST
- Obesity bet may drive focus on chronic segment: Alkem LabsAlkem Labs anticipates its upcoming semaglutide launch will drive a strategic shift from acute treatments to chronic care, including diabet...21 Mar, 2026, 01.07 AM IST
- Natco Pharma, 3 other pharma stocks decline up to 2.5% after important inspections at their units. Do you own?Indian pharmaceutical stocks, including Lupin, Shilpa Medicare, and Natco Pharma, are under scrutiny following recent USFDA inspections at ...24 Nov, 2025, 10.19 AM IST
- Lupin, Glenmark Pharma, 7 BSE Healthcare stocks which hit 52-week high on WednesdayThe data was sourced from BSE at 2.50 pm, and the updates from the real-time data could come with a lag. The below data also pertains only ...09 Aug, 2023, 05.39 PM IST
- Buy Alkem Lab, target price Rs 3,300: Angel BrokingThe pharma company is expected to outperform the Indian Pharmaceutical market (IPM) by 1.5 times growth rate for the next 2 years.19 May, 2020, 12.33 PM IST
- Adrenaline Rush: This drug firm is up 32% in 40 days, and is ready to rallyThe stock has been a darling of mutual funds and foreign institutional investors (FIIs).11 Feb, 2020, 01.30 PM IST
- Stock pick of the week: Why analysts are betting on Alkem LabsA rise in margins in the coming years, improved domestic business, leadership position in some segments, and the correction in its stock pr...29 Apr, 2019, 06.30 AM IST
- Accumulate Alkem Laboratories, target Rs 2,441: Angel BrokingAccumulate Alkem Laboratories Ltd. at a price target of Rs 2441.0 .12 Mar, 2018, 07.52 AM IST
- Cipla to market Novartis, and J&J’s products, while Alkem partners Dong A of South KoreaAlkem is bringing in a fresh brand. Evogliptin has been approved in South Korea and the company is waiting for an approval from the USFDA a...08 Feb, 2018, 12.06 PM IST
- 2015: Best year for IPOs since 2010; Dr Lal surges 50%, Alkem gains 31% on street debutOn Dr Lal PathLabs, Bansal said valuation of the company appears expensive after the strong listing and investors should wait for the compa...24 Dec, 2015, 05.57 AM IST
- Play out on stocks which are cheaper in secondary markets rather than Alkem or Pathlabs: Sandip SabharwalPeople used to buy pharma stocks for the overseas business, but with the regulatory issues, it is getting tougher now.23 Dec, 2015, 02.17 PM IST
- Alkem Labs May Inspire Other Pharma Cos to Take IPO PathWith many unlisted cos in sector, chances of them tapping mkt looks high: Nomura Fin's Oza.04 Dec, 2015, 11.11 AM IST
- Drug regulator wants multi-vitamins to be classified as 'drugs'Among the 10 products that have been mentioned in the proposal are Sun Pharma's multi-vitamin capsule 'Revital', Pfizer's 'Ferradol' and Al...17 Sep, 2015, 04.00 AM IST
- Pharmaceutical company Alkem Laboratories eyeing big-bang IPO in FY-1580% of the company's revenues currently come from domestic operations and now it's main focus is on the US market.13 Jan, 2015, 08.40 PM IST
Load More
